135 related articles for article (PubMed ID: 37806641)
21. Connecting the Dots: Therapy-Induced Senescence and a Tumor-Suppressive Immune Microenvironment.
Vilgelm AE; Johnson CA; Prasad N; Yang J; Chen SC; Ayers GD; Pawlikowski JS; Raman D; Sosman JA; Kelley M; Ecsedy JA; Shyr Y; Levy SE; Richmond A
J Natl Cancer Inst; 2016 Jun; 108(6):djv406. PubMed ID: 26719346
[TBL] [Abstract][Full Text] [Related]
22. p15
Park SS; Lee YK; Park SH; Lim SB; Choi YW; Shin JS; Kim YH; Kim JH; Park TJ
Heliyon; 2023 Feb; 9(2):e13170. PubMed ID: 36785830
[TBL] [Abstract][Full Text] [Related]
23. Escape From Cisplatin-Induced Senescence of Hypoxic Lung Cancer Cells Can Be Overcome by Hydroxychloroquine.
Olszewska A; Borkowska A; Granica M; Karolczak J; Zglinicki B; Kieda C; Was H
Front Oncol; 2021; 11():738385. PubMed ID: 35127467
[TBL] [Abstract][Full Text] [Related]
24. The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort.
Damotte D; Warren S; Arrondeau J; Boudou-Rouquette P; Mansuet-Lupo A; Biton J; Ouakrim H; Alifano M; Gervais C; Bellesoeur A; Kramkimel N; Tlemsani C; Burroni B; Duche A; Letourneur F; Si H; Halpin R; Creasy T; Herbst R; Ren X; Morel P; Cesano A; Goldwasser F; Leroy K
J Transl Med; 2019 Nov; 17(1):357. PubMed ID: 31684954
[TBL] [Abstract][Full Text] [Related]
25. IFN-γ and TNF Induce Senescence and a Distinct Senescence-Associated Secretory Phenotype in Melanoma.
Homann L; Rentschler M; Brenner E; Böhm K; Röcken M; Wieder T
Cells; 2022 Apr; 11(9):. PubMed ID: 35563820
[TBL] [Abstract][Full Text] [Related]
26. Senescence-Induced Chemoresistance in Triple Negative Breast Cancer and Evolution-Based Treatment Strategies.
Chakrabarty A; Chakraborty S; Bhattacharya R; Chowdhury G
Front Oncol; 2021; 11():674354. PubMed ID: 34249714
[TBL] [Abstract][Full Text] [Related]
27. Synthetic lethal metabolic targeting of cellular senescence in cancer therapy.
Dörr JR; Yu Y; Milanovic M; Beuster G; Zasada C; Däbritz JH; Lisec J; Lenze D; Gerhardt A; Schleicher K; Kratzat S; Purfürst B; Walenta S; Mueller-Klieser W; Gräler M; Hummel M; Keller U; Buck AK; Dörken B; Willmitzer L; Reimann M; Kempa S; Lee S; Schmitt CA
Nature; 2013 Sep; 501(7467):421-5. PubMed ID: 23945590
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous Imaging and Flow-cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-induced Senescent Cancer Cells.
Dovjak E; Mairhofer M; Wöß C; Qi J; Fan DNY; Schmitt CA; Yu Y
J Vis Exp; 2022 Jul; (185):. PubMed ID: 35913198
[TBL] [Abstract][Full Text] [Related]
29. Nutritional Niches of Cancer Therapy-Induced Senescent Cells.
Llop-Hernández À; Verdura S; Cuyàs E; Menendez JA
Nutrients; 2022 Sep; 14(17):. PubMed ID: 36079891
[TBL] [Abstract][Full Text] [Related]
30. Decreased skp2 expression is necessary but not sufficient for therapy-induced senescence in prostate cancer.
Ewald JA; Jarrard DF
Transl Oncol; 2012 Aug; 5(4):278-87. PubMed ID: 22937180
[TBL] [Abstract][Full Text] [Related]
31. The Expression of the Senescence-Associated Biomarker Lamin B1 in Human Breast Cancer.
Saleh T; Alhesa A; El-Sadoni M; Abu Shahin N; Alsharaiah E; Al Shboul S; Awad H; Bloukh S; Al-Balas M; Alsalem M; Azab B; Aladily TN
Diagnostics (Basel); 2022 Feb; 12(3):. PubMed ID: 35328162
[TBL] [Abstract][Full Text] [Related]
32. MethCORR infers gene expression from DNA methylation and allows molecular analysis of ten common cancer types using fresh-frozen and formalin-fixed paraffin-embedded tumor samples.
Mattesen TB; Andersen CL; Bramsen JB
Clin Epigenetics; 2021 Jan; 13(1):20. PubMed ID: 33509261
[TBL] [Abstract][Full Text] [Related]
33. A signature of enhanced lipid metabolism, lipid peroxidation and aldehyde stress in therapy-induced senescence.
Flor AC; Wolfgeher D; Wu D; Kron SJ
Cell Death Discov; 2017; 3():17075. PubMed ID: 29090099
[TBL] [Abstract][Full Text] [Related]
34. Distinct mechanisms mediating therapy-induced cellular senescence in prostate cancer.
Kallenbach J; Atri Roozbahani G; Heidari Horestani M; Baniahmad A
Cell Biosci; 2022 Dec; 12(1):200. PubMed ID: 36522745
[TBL] [Abstract][Full Text] [Related]
35. Senescence and the tumor-immune landscape: Implications for cancer immunotherapy.
Chibaya L; Snyder J; Ruscetti M
Semin Cancer Biol; 2022 Nov; 86(Pt 3):827-845. PubMed ID: 35143990
[TBL] [Abstract][Full Text] [Related]
36. Doxorubicin-induced senescence promotes stemness and tumorigenicity in EpCAM-/CD133- nonstem cell population in hepatocellular carcinoma cell line, HuH-7.
Karabicici M; Alptekin S; Fırtına Karagonlar Z; Erdal E
Mol Oncol; 2021 Aug; 15(8):2185-2202. PubMed ID: 33524223
[TBL] [Abstract][Full Text] [Related]
37. Combination of PARP inhibitor and CDK4/6 inhibitor modulates cGAS/STING-dependent therapy-induced senescence and provides "one-two punch" opportunity with anti-PD-L1 therapy in colorectal cancer.
Wang T; Liu W; Shen Q; Tao R; Li C; Shen Q; Lin Y; Huang Y; Yang L; Xie G; Bai J; Li R; Wang L; Tao K; Yin Y
Cancer Sci; 2023 Nov; 114(11):4184-4201. PubMed ID: 37702298
[TBL] [Abstract][Full Text] [Related]
38. Non-Cell Autonomous Effects of the Senescence-Associated Secretory Phenotype in Cancer Therapy.
Saleh T; Tyutynuk-Massey L; Cudjoe EK; Idowu MO; Landry JW; Gewirtz DA
Front Oncol; 2018; 8():164. PubMed ID: 29868482
[TBL] [Abstract][Full Text] [Related]
39. Prognostic implications of cellular senescence in resected non-small cell lung cancer.
Domen A; Deben C; De Pauw I; Hermans C; Lambrechts H; Verswyvel J; Siozopoulou V; Pauwels P; Demaria M; van de Wiel M; Janssens A; Hendriks JMH; Van Schil P; Vermorken JB; Vandamme T; Prenen H; Peeters M; Lardon F; Wouters A
Transl Lung Cancer Res; 2022 Aug; 11(8):1526-1539. PubMed ID: 36090630
[TBL] [Abstract][Full Text] [Related]
40. Robust transcriptional tumor signatures applicable to both formalin-fixed paraffin-embedded and fresh-frozen samples.
Chen R; Guan Q; Cheng J; He J; Liu H; Cai H; Hong G; Zhang J; Li N; Ao L; Guo Z
Oncotarget; 2017 Jan; 8(4):6652-6662. PubMed ID: 28036264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
